Lv5
1535 积分 2020-10-02 加入
DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers
1天前
待确认
Translating Preclinical Studies into the Clinic: Assays and Endpoints Selected to Determine Efficacy
19天前
已关闭
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
20天前
已关闭
Rewriting lysine reactivity: Lysine-targeted bioconjugation via biomimetic polarity reversal for diversified biomolecule modification
20天前
已关闭
When Checkpoint Inhibitors Break Barriers: Mechanisms and Challenges of irAEs of the Skin, Gastrointestinal Tract, and Lung
20天前
已关闭
Translating Preclinical Studies into the Clinic: Assays and Endpoints Selected to Determine Efficacy
20天前
已关闭
Causes of Death in Patients with Cancer: A Scoping Review
20天前
已关闭
Lessons learned in linking PROTACs from discovery to the clinic
20天前
已关闭
Toxicities From Antibody-Drug Conjugates
26天前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
1个月前
已关闭
皖公网安备34019202002308
